apagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Description

DComposition: Each extended-release tablet contains:

• Dapagliflozin 10 mg

• Sitagliptin 100 mg

• Metformin Hydrochloride (ER) 1000 mg

Dosage Form: Tablet (Extended Release)
Route of Administration: Oral
Drug Class:

• Dapagliflozin – SGLT2 Inhibitor (Sodium-Glucose Co-Transporter 2 Inhibitor)

• Sitagliptin – DPP-4 Inhibitor (Dipeptidyl Peptidase-4 Inhibitor)

• Metformin Hydrochloride – Biguanide Antidiabetic Agent

Therapeutic Use: Management of type 2 diabetes mellitus to improve glycemic control in adults as an adjunct to diet and exercise.